These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 16547278)

  • 1. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
    Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
    J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.
    McColl SR; Mahalingam S; Staykova M; Tylaska LA; Fisher KE; Strick CA; Gladue RP; Neote KS; Willenborg DO
    Lab Invest; 2004 Nov; 84(11):1418-29. PubMed ID: 15322564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
    Carter SL; Müller M; Manders PM; Campbell IL
    Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
    Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
    Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice.
    Heneka MT; Sharp A; Murphy P; Lyons JA; Dumitrescu L; Feinstein DL
    J Neurochem; 2001 Apr; 77(2):568-79. PubMed ID: 11299319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.
    Narumi S; Kaburaki T; Yoneyama H; Iwamura H; Kobayashi Y; Matsushima K
    Eur J Immunol; 2002 Jun; 32(6):1784-91. PubMed ID: 12115662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
    Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
    J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
    Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
    Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.
    Müller M; Carter SL; Hofer MJ; Manders P; Getts DR; Getts MT; Dreykluft A; Lu B; Gerard C; King NJ; Campbell IL
    J Immunol; 2007 Sep; 179(5):2774-86. PubMed ID: 17709491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR3: an unexpected enigma.
    Liu L; Callahan MK; Huang D; Ransohoff RM
    Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.
    O'Connor RA; Li X; Blumerman S; Anderton SM; Noelle RJ; Dalton DK
    J Immunol; 2012 Mar; 188(5):2093-101. PubMed ID: 22287719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.